Test Price
2,800 AED✅ Home Collection Available
GLI3 Gene Greig Cephalopolysyndactyly Syndrome Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين GLI3 لمتلازمة جريج الرأسية متعددة الأصابع والارتفاق في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Certified Cold-Chain Processing and NGS Technology.
- Premium Logistics: Paid Hospital-Grade Home Collection by ISO Certified Phlebotomists, with VIP Mobile Phlebotomy available 8 AM–11 PM.
- Clinical Guidance: Post‑Test Telephonic Clinical Guidance by DHA‑licensed specialists to interpret results.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
ملخص تنفيذي
فحص دقيق لجين GLI3 باستخدام تقنية التسلسل الجيني من الجيل التالي (NGS) بدقة 99.9%، معتمد دولياً من هيئة الصحة بدبي، تحت إشراف الدكتور برابهاكار ريدي (ترخيص هيئة الصحة 61713011) لضمان أعلى معايير الجودة والسلامة.
Overview
This Next‑Generation Sequencing (NGS) test sequences the full coding regions of the GLI3 gene to detect pathogenic variants responsible for Greig cephalopolysyndactyly syndrome (GCPS). Conducted in our DHA‑licensed, ISO‑certified laboratory, it ensures 99.9% diagnostic sensitivity for accurate clinical decision‑making.
فحص جيني متقدم لتشخيص متلازمة جريج بدقة عالية، معتمد من هيئة الصحة بدبي.
| Feature | Our GLI3 NGS Test | Whole Exome Sequencing (Alternative) |
|---|---|---|
| Precision | Full gene coverage, deep sequencing ≥100x | Broad but may miss deep intronic variants |
| Methodology | Targeted NGS, Sanger validation | Whole exome capture, bioinformatic filtering |
| Turnaround Time | 3–4 Weeks | 6–8 Weeks (complex analysis) |
| Price (AED) | 2800 | 6000+ |
Physician Insight & DHA Clinical Guidance
Dr. Prabhakar Reddy (DHA License: 61713011) notes: “Facing a possible syndromic diagnosis can be daunting, but this test is a tool of empowerment. My team ensures that every result is contextualized with your child’s unique clinical picture, because genes tell only part of the story. We offer compassionate post‑test counselling to help you navigate the next steps confidently.”
Safety & Exclusion Criteria
- Do not discontinue any prescribed medication without prior physician approval.
- This test requires informed consent and pre‑test genetic counselling (pedigree chart required).
- Not suitable for emergency prenatal diagnosis; a dedicated genetic counsellor must be consulted beforehand.
- Red Flags: If you experience severe pain, bleeding, or signs of infection after sample collection, seek emergency care immediately.
- Variants of uncertain significance (VUS) may be reported; additional family studies may be recommended.
Pre‑Test Information & Logistics
Required Sample: Blood (EDTA), Extracted DNA, or One drop blood on FTA Card. Home collection available 8 AM–11 PM via VIP Mobile Phlebotomy.
Preparations: No fasting required. Provide complete clinical history including phenotypic details. A mandatory genetic counselling session will record a three‑generation pedigree of affected family members. No drug or supplement avoidance is necessary.
Frequently Asked Questions
1. What does the GLI3 genetic test diagnose?
This NGS test detects disease‑causing variants in the GLI3 gene responsible for Greig cephalopolysyndactyly syndrome, a rare autosomal dominant disorder.
يكشف هذا الفحص الجيني المتقدم عن الطفرات المسببة للمرض في جين GLI3 المسؤول عن متلازمة جريج الرأسية متعددة الأصابع والارتفاق.
2. Why is genetic counselling required before testing?
Pre‑test counselling ensures a thorough understanding of potential outcomes, inheritance patterns, and helps draw a detailed family pedigree essential for variant interpretation.
جلسة الاستشارة الوراثية ضرورية لفهم النتائج المحتملة وأنماط الوراثة، وتساعد في رسم شجرة العائلة لتفسير الطفرات بدقة.
3. How soon will I receive my results?
Results are delivered within 3 to 4 weeks, accompanied by a telephonic post‑test guidance session to discuss findings and next clinical steps.
تصدر النتائج خلال 3 إلى 4 أسابيع، تليها جلسة إرشاد هاتفية بعد الفحص لمناقشة النتائج والخطوات السريرية التالية.
UAE Regulatory Compliance: This adheres to Federal Decree‑Law No. 41 of 2024 (Art. 87) on genetic testing, the CDS Law 2026 (Minors), and the UAE Personal Data Protection Law (PDPL). Facility licensed by DHA (License: 9834453), ISO 9001:2015 certified (Cert: INT/EGQ/2509DA/3139). All genetic data are processed in the UAE with strict confidentiality.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians